Impact of patient engagement in a French telemonitoring programme for heart failure on hospitalization and mortalityESC HEART FAILUREIF3.72022-06-1714OA
Burden of severe spondyloarthritis in France: A nationwide assessment of prevalence, associated comorbidities and costJOINT BONE SPINEIF4.32019-01-0110OAAI
Early non-response to certolizumab pegol in rheumatoid arthritis predicts treatment failure at one year. Data from a randomised phase III clinical trialJOINT BONE SPINEIF4.32018-01-019OAAI
GENDER, DISEASE ACTIVITY, ANXIETY AND DEPRESSION LEVELS ARE RELATED TO THE LEVELS OF FEARS OF PATIENTS WITH RHEUMATOID ARTHRITIS OR AXIAL SPONDYLOARTHRITIS: A CROSS-SECTIONAL STUDY OF 672 PATIENTSANNALS OF THE RHEUMATIC DISEASESIF20.62016-06-011PREAI
LIFESTYLE BELIEFS OF 672 PATIENTS WITH RHEUMATOID ARTHRITIS OR AXIAL SPONDYLOARTHRITISANNALS OF THE RHEUMATIC DISEASESIF20.62016-06-011PREAI
PREVALENCE, COMORBIDITIES AND BURDEN OF SEVERE SPONDYLOARTHRITIS IN FRANCE: ANALYSIS OF A NATIONAL PUBLIC HEALTH INSURANCE DATABASE IN 2012 IN FRANCEVALUE IN HEALTHIF62015-11-012OAAI
THE MOST FREQUENT FEARS AND BELIEFS OF 226 PATIENTS WITH RHEUMATOID ARTHRITIS OR SPONDYLOARTHRITIS, USING A NOVEL QUESTIONNAIREVALUE IN HEALTHIF62015-11-012OAAI
DEVELOPMENT AND VALIDATION OF A QUESTIONNAIRE ASSESSING THE FEARS AND BELIEFS OF PATIENTS SUFFERING FROM CHRONIC RHEUMATIC DISEASESVALUE IN HEALTHIF62015-11-011OAAI
THE MOST FREQUENT FEARS AND BELIEFS OF 226 PATIENTS WITH RHEUMATOID ARTHRITIS OR SPONDYLOARTHRITIS, USING A NOVEL QUESTIONNAIREANNALS OF THE RHEUMATIC DISEASESIF20.62015-06-011PREAI
DEVELOPMENT AND VALIDATION OF A QUESTIONNAIRE ASSESSING THE FEARS AND BELIEFS OF PATIENTS SUFFERING FROM CHRONIC RHEUMATIC DISEASESANNALS OF THE RHEUMATIC DISEASESIF20.62015-06-011PREAI
PREVALENCE DETERMINATION OF SEVERE ANKYLOSING SPONDYLITIS AND ITS CO-MORBIDITIES IN 2012 IN FRANCE: ANALYSIS OF A NATIONAL PUBLIC HEALTH INSURANCE DATABASEANNALS OF THE RHEUMATIC DISEASESIF20.62015-06-011PREAI
COST-EFFECTIVENESS MODELLING OF A 3-MONTH TIGHT CONTROL PATIENT MANAGEMENT OF RHEUMATOID ARTHRITIS WITH CERTOLIZUMAB PEGOL IN FRANCEVALUE IN HEALTHIF62013-11-010OAAI
EARLY RESPONSE TO CERTOLIZUMAB PEGOL IN RHEUMATOID ARTHRITIS PREDICTS OUTCOME AT ONE YEARVALUE IN HEALTHIF62013-11-010OAAI